SETD2 and nonpapillary renal cell carcinoma: Recently, Bui et al. published the first meta-analysis of genomic data from ccRCC tumors, reporting the four most commonly mutated genes in ccRCC–VHL, PBRM1, SETD2, and BAP1–with mutation prevalences of 64%, 36%, 20%, and 13%, respectively [14].